Powering Bias and Clinically Important Treatment Effects in Randomized Trials of Critical Illness*

Abstract

The design of most high-impact critical care trials biased results toward the null by overestimating control group mortality and powering for unrealistic treatment effects. Clinically important treatment effects often cannot be excluded.